17. atopy, allergy and delayed type hypersensitivity Flashcards

1
Q

allergen definition

A

substance to which IgE antibodies may be produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

early phase allergic reaction

A

in allergic individuals, allergen exposure lead to rapid development of symptoms (seconds-minutes)
allergens bind to IgE antibodies on mast cells and basophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IgE ligation in allergy

A

IgE binds specific allergen
cross-linking of IgE by allergen beads to clustering of receptors
intracellular portion of receptor becomes phosphorylates
intracellular cascade leads to cell activation
mast cells degranulate - release histamine, tryptase and other preformed mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

leukotrienes

A

delayed mediators
similar pharmacological effect to histamine
phospholipase A2 from mast cell activation starts pathway
derived from arachidonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pharmacological effects of mast cell mediators and leukotrienes

A

skin - wheal and flare
nose - discharge, sneezing
eyes - conjunctivitis
lungs - wheeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mast cell activation and granule release - GI tract

A

increased fluid secretion
increased peristalsis
expulsion on gastrointestinal tract contents (diarrhoea, vomiting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mast cell activation and granule release - airways

A

decreased diameter
increased mucus secretion
congestion and blockage of airways (wheezing, coughing, phlegm)
swelling and mucus secretion in nasal passages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mast cell activation and granule release - blood vessels

A

increased blood flow
increased permeability
increased fluid in tissues - increased flow of lymph to lymph nodes, increased cells and protein in tissues
increased effector response in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

allergen sources

A

almost always otherwise innocuous environmental proteins

pollen, house dust mite faeces, stinging insect venom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

general characteristics of allergens

A

proteins (minor exceptions) - only protein can produce T/B cell response
physical properties favour transition across mucus membrane (soluble, low molecular weight)
biologically active (often enzymes)
moderate homology with self-proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clinical allergy syndromes: anaphylaxis

A

generalised allergic reaction
systemic release of histamine
causes generalised vasodilation and fluid loss from circulation into tissues
foods, drugs and insect venom = most common in UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

anaphylaxis symptoms

A

hives, angioedema
vomiting, diarrhoea, laryngeal oedema, bronchoconstriction
vasodilatation, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

anaphylaxis cardinal features

A

typical symptoms
multi-system and dramatic
rapidly follows exposure to allergen
tends to improve quickly thereafter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clinical allergy syndromes: oral allergy syndrome

A

most common type of food allergy in the UK
IgE against pollen proteins cross-reacts with homologous proteins in plant-derived food
oral itching on exposure to raw fruit, nuts and vegetables
UK - pollen mainly birch, food mainly Rosaceae fruits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical allergy syndromes: airway disease

A

rhinitis - sneezing, rhinorrhoea, blockage (type 1 allergy)
lower airway obstruction - wheeze (type 1 allergy)
allergens may be seasonal (pollens) or episodic (animal dander)
when symptoms are chronic, inflammation becomes established - cannot be explained by mast cell degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

immunological tightrope

A

self vs non self
dangerous infection vs commensal organisms
environmental allergens, food/pollen
activation for defence vs tolerance to prevent autoimmune and inflammatory diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

origins of allergic disease

A

allergic/atopic math - progression of disease observed from infancy
eczema, food allergy, rhinitis, asthma
most children outgrow eczema and many food allergies
rhinitis/asthma may or may not be outgrown
allergic disease may present de novo in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

chronic allergic inflammation: asthma

A

ongoing symptoms
most patients are sensitised to variety of airborne allergens
biopsy shows inflammatory infiltrate and airway changes (remodelling - thickened basement membrane, smooth muscle hyperplasia)
early allergic reaction phase does not provide good explanation by itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

late phase allergic reaction

A

early phase reaction is followed some hours later by a late phase reaction
biopsy of let tase shows infiltration with inflammatory cells
CD4 T cells, eosinophils, mast cells in particular
some insight into chronic allergic inflammation

20
Q

T cell subsets (CD4)

A

Th1 - releases IFN gamma
Th2 - releases IL-4,-5,-9,-13
Th17- releases IL-17
Treg - releases IL-10, contact dependent mechanisms

21
Q

Th2 hypothesis

A

Th2 responses to allergens consistently associated with allergic disease
biopsies of allergic inflammation are rich in T cells expressing Th2 cytokines

22
Q

why might Th2 be important in allergy?

A

IL-4 required for B cell class switching to IgE
IL-4 and IL-13 promotes mucus hypersecretion
IL-5 required for eosinophil survival
IL-9 recruits mast cells

23
Q

asthma acute responses

A

inflammatory mediators cause increased mucus secretion and smith muscle contraction - leads too airway obstruction
cells are recruited from the circulation

24
Q

asthma chronic responses

A

caused by cytokines and eosinophil products

25
genetics
childhood allergy strongly predicted by parent with allergy | numerous genetic risk factors identified
26
hygiene hypothesis
low hygiene levels, high pathogen load and helminth infection = immunity skewed to Th1, Treg cells induced high hygiene levels, low pathogen load, no helminth infection = immunity skewed to Th2, reduced production of Treg cells
27
detection of allergen specific IgE in vivo
skin prick testing allergen extract applied as drops top layers of epidermis punctured with lan net wheal and flare response within 15 mins = positive result needs interpretation in clinical context
28
detection of allergen specific IgE in vitro
usually ELISA purified allergen, stuck, incubated with sera IgE antibodies in sera binds to allergen immobilised IgE antibodies detected with detection antibody
29
allergy treatment
``` symptom relievers drugs acting on early phase mediators corticosteroids monoclonal antibodies immunotherapy ```
30
allergy symptom relievers
``` nasal decongestants - eg. oxymetazoline - alpha 1 adrenoreceptors - cause vasoconstriction - short term b2 agonists - eg salbutamol - act on lung adrenoreceptors - cause smooth muscle relaxation adrenaline - systemic adrenergic effects - oppose vasodilation and bronchconstriction ```
31
drugs acting on early phase mediators
mast cell stabilisers H1 antihistamines leukotriene receptor antagonists
32
mast cell stabilisers
``` eg sodium cromoglycate reduce mast cell degranulation (unknown mechanism) topical only short half life main benefit = steroid free ```
33
H1 antihistamines
inverse agonists at H1 histamine receptor best used before exposure to allergen 1st generation: clorpheniramine (sedation, drug interactions) 2nd generation: cerizine, loratadine (minimal/no sedation)
34
leukotriene receptor antagonists
only UK drug = montelukast effective in reducing early allergic responses inferior to H1 antihistamines beneficial in chronic asthma
35
corticosteroids
reduce immune activation alter gene expression in T cells, B cells, and cells of the innate immune system onset of action is delayed
36
omalizumab
monoclonal antibody directed against IgE used for atopic asthma
37
allergen specific immunotherapy
allergen doses administered by subcutaneous injection long term protection mainly venom allergy and rhinitis
38
immunotherapy immunological effects
``` induce Treg cell responses to allergens reduce Th2 responses induce allergen-specific IgG antibodies reduction in mast cell responsiveness reduce allergen-specific IgE levels ```
39
delayed type hypersensitivity
mediated by antigen specific effector T cells
40
antigen specific definition
implies that a specific antigen stimulus is required, chichis them processed and presented to relevant T cells responsible for reaction
41
effector T cell definition
T cells that have previously met antigen, and are 'primed' to produce a rapid and robust response
42
contact dermatitis - sensitisation
molecules react with self proteins to create protein-hapten complexes complexes are picked up by Langerhans cells which migrate to lymph nodes Langerhans cells process and present antigen on MHC class II in some individuals, complexes are recognised as foreign activated T cells migrate to the dermis
43
hapten
small molecule that cannot individually invoke an immune response, but can bind to protein to alter its immunogenicity
44
contact dermatitis - elicitation
chemokines recruit macrophages Th1 cells secrete IFN gamma (increases expression of vascular adhesion molecules, activates macrophages) TNF alpha/beta stimulates local inflammation
45
poison ivy
poison ivy lipid can cross skin and modify intracellular proteins proteins are processed and presented on MHC class I to T cells causes contact dermatitis not everyone is susceptible
46
patch testing for contact dermatitis
antigen impregnated patch placed on back nickel, chrome, epoxy resin etc read after 2 days